2021 Revenues ($USD) : $11,673,000,000
2021 R&D spend : $521,000,000
2021 Number of Employees : 50,000
Fiscal Year End : 12/31/2020
Key People : ​José Almeida, chairperson, president and CEO; Giuseppe Accogli, SVP and president, Americas and global business units; Paulo Bolgar, VP, human resources, Americas, global business units and R&D; David Bondi, chief procurement officer; Wil Boren, president, advanced surgery; James Borzi, SVP, chief supply chain officer; Ellen Bradford, SVP and corporate secretary; Gavin Campbell, GM, U.S. renal; Dennis Crowley, SVP, business development and licensing; Stacey Eisen, SVP, global communications and president, Baxter International Foundation; Robert Felicelli, head, global technical services; Cristiano Franzi, SVP and president, EMEA; Andrew Frye, SVP and president, APAC; Andy Goldney, VP, medication delivery and pharmaceuticals - Europe; Jessica Hameline, VP, global digital transformation office; Tobi Karchmer, VP, worldwide medical; Heather Knight, GM, U.S. hospital products; Jacqueline Kunzler, SVP, chief quality officer; Karen Leets, SVP and treasurer; Talvis Love, SVP and chief information officer; Sean Martin, SVP and general counsel; Jeanne Mason, SVP, human resources; Piero Novello, GM, Baxter Mexico, Central and South America; Lynn Pawelski, VP, global regulatory affairs; John Quick, VP, finance, Americas and global business units; Sumant Ramachandra, president, pharmaceuticals and SVP, chief science and technology officer; Reaz Rasul, GM, acute therapies; Jon Rushford, VP, integrated supply chain - Americas; James Saccaro, EVP and CFO; Joseph Schwan, deputy general counsel, global government policy and reimbursement; Brian Stevens, SVP, chief accounting officer and controller; Clare Trachtman, VP, investor relations; Jorge Vasseur, GM, clinical nutrition; Heather Wechet, VP, human resources, global functions, talent management and employee relations; Shirley Xu, GM, Greater China.

About the company: Founded in 1931 as the Don Baxter Intravenous Products Corp. by two doctors — Ralph Falk and Don Baxter — Baxter was the first commercial manufacturer of prepared IV solutions and developed the Transfuso-Vac container for blood collection and storage, allowing for blood bank storage of up to three weeks. Baxter Laboratories, as it later called itself, opened its first manufacturing facility in a former auto showroom in Glenview, Illinois. Baxter now provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies, sterile intravenous solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products. Baxter’s customers are hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and patients at home under physician supervision. The Deerfield, Illinois-based company manufactures products in more than 20 countries and sells them in more than 100 countries. Baxter remains on track to complete its $12.4 billion acquisition of Hillrom, which is expected to close in 2022.  –JH